다양한 임상양상을 보이는 두경부의 이식 후 림프증식성 질환: 3예
Various Clinical Presentation of Post-Transplant Lymphoproliferative Disorder in Head and Neck: A Case Series of 3 Patients
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The outcome of solid organ and bone marrow transplantation has been dramatically improvedwith the development of immunosuppressive agent. However, the use of immunosuppressiveagents could increase the risk of malignancies such as post-transplant lymphoproliferative disorder(PTLD). PTLD is regarded as the lymphoid malignancy of patients using immunosuppressiveagents, and it could present diverse and non-specific symptoms. It involves variousorgans including the tonsil, adenoid, lymph node, and the brain. Because of its poor prognosis,an early suspicion of pathologic diagnosis is crucial for the treatment of PTLD. In this report,we demonstrate the case of three pediatric patients who had been treated for PTLD of variousclinical presentations by early suspicion and pathologic diagnosis.
Abstract
The outcome of solid organ and bone marrow transplantation has been dramatically improvedwith the development of immunosuppressive agent. However, the use of immunosuppressiveagents could increase the risk of malignancies such as post-transplant lymphoproliferative disorder(PTLD). PTLD is regarded as the lymphoid malignancy of patients using immunosuppressiveagents, and it could present diverse and non-specific symptoms. It involves variousorgans including the tonsil, adenoid, lymph node, and the brain. Because of its poor prognosis,an early suspicion of pathologic diagnosis is crucial for the treatment of PTLD. In this report,we demonstrate the case of three pediatric patients who had been treated for PTLD of variousclinical presentations by early suspicion and pathologic diagnosis.
참고문헌 (14)
- Boubenider S, "Incidence and consequences of post-transplantation lymphoproliferative disorders", J Nephrol, 10(3), pp.136~145 (1997)
- Mynarek M, "Posttransplant lymphoproliferative disease after pediatric solid organ transplantation", Clin Dev Immunol, 2013, pp.814973~ (2013)
- Got tschalk S, "Post-t ransplant lymphoproliferative disorders", Annu Rev Med, 56, pp.29~44 (2005)[DOI]
- Webber SA, "Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study", Lancet, 367(9506), pp.233~239 (2006)[DOI]
- Shroff R, "The post-transplant lymphoproliferative disorder-a literature review", Pediatr Nephrol, 19(4), pp.369~377 (2004)[DOI]
- Evens AM, "Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era", J Clin Oncol, 28(6), pp.1038~1046 (2010)[DOI]
- Engels EA, "Spectrum of cancer risk among US solid organ transplant recipients", JAMA, 306(17), pp.1891~1901 (2011)[DOI]
- Weinstock DM, "Preemptive diagnosis and treatment of Epstein-Barr virusassociated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development", Bone Marrow Transplant, 37(6), pp.539~546 (2006)[DOI]
- Lim WH, "Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation", Nephrology (Carlton), 11(4), pp.355~366 (2006)[DOI]
- Starzl TE, "Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy", Lancet, 1(8377), pp.583~587 (1984)
- Loren AW, "Post-transplant lymphoproliferative disorder: a review", Bone Marrow Transplant, 31(3), pp.145~155 (2003)[DOI]
- Mucha K, "Tonsil enlargement after liver transplantation in adults--reason enough for tonsillectomy? Two cases of tonsillar posttransplantation lymphoproliferative disease", Liver Transpl, 13(6), pp.918~923 (2007)[DOI]
- Elstrom RL, "Treatment of PTLD with rituximab or chemotherapy", Am J Transplant, 6(3), pp.569~576 (2006)[DOI]
- Nalesnik MA, "The diverse pathology of post-t ransplant lymphoproliferative disorders: the importance of a standardized approach", Transpl Infect Dis, 3(2), pp.88~96 (2001)[DOI]